The NASH: Take Action! six-episode podcast series features interviews with world-renowned experts in NAFLD, NASH and metabolic syndrome providing practical information for health care professionals on screening, diagnosing and managing these conditions. Collect up to 6 AMA PRA Category 1 credits for this activity by visiting nash.gastro.org.
We close out this series chatting with Hashem El-Serag, MD, Baylor College of Medicine, about collaboration between primary care providers and specialists in managing patients with NAFLD and NASH. This is the final episode in our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. To collect CME credit for listening, visit nash.gastro.org.
Robert H. Eckel, MD, University of Colorado, discusses limitations in current data about managing NAFLD and NASH and emerging therapies. This is episode 5 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. To collect CME credit for listening, visit nash.gastro.org.
Vincent Wong, MD, The Chinese University of Hong Kong, provides insights into noninvasive diagnostic techniques for patients at high risk for NASH and the role of liver biopsy in diagnosing NASH. This is episode 4 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. To collect CME credit for listening, visit nash.gastro.org.
Kim Pfotenhauer, DO, Michigan State University, and Eugene Wright, MD, Duke University, discuss screening people for NAFLD in the primary care setting. This is episode 3 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. To collect CME credit for listening, visit nash.gastro.org.
Lee Kaplan, MD, founding director of the Weight Center at Massachusetts General Hospital, discusses the relationship between NASH, obesity and associated comorbidities. This is episode 2 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. To collect CME credit for listening, visit nash.gastro.org.
This is episode 1 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care talk about the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. We start with a discussion on the prevalence of NAFLD and NASH and their clinical and economic burdens with guest Zobair Younossi, MD, president, medicine service line, Inova Health System. To collect CME credit for listening, visit nash.gastro.org.
This is episode 1 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Naresh Gunaratnam to discuss: • Weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastrointestinal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer. • Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss. To collect CME credit for listening, visit agau.gastro.org.
This is episode 2 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Colleen Tewksbury to discuss: • A deep dive into dietary approaches for obesity management including debating low carb versus low fat diets. • Misconceptions that society has about dietary approaches to weight loss. • The importance of an individualized approach versus a cure-all for everyone. To collect CME credit for listening, visit agau.gastro.org.
This is episode 3 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). In this episode, our host Dr. Andres Acosta is joined by Dr. Janese Laster to discuss: • Gastroenterologists and the GI care team should embrace obesity care as weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastroesophageal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer. • Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss. • Updates on medications for obesity management that are available now and a look into what may be available in the future. To collect CME credit for listening, visit agau.gastro.org.
This is episode 4 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). In this episode, our host Dr. Andres Acosta is joined by Dr. Barham Abu Dayyeh to discuss: • Gastroenterologists and the GI care team should embrace obesity care as weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastroesophageal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer. • Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss. • Updates on devices for obesity management that are available now and a look into what may be available in the future. To collect CME credit for listening, visit agau.gastro.org.
This is episode 5 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). In this episode, our host Dr. Andres Acosta is joined by Dr. John Magaña Morton to discuss: • Evaluating patient outcomes and measuring weight loss success in terms of reduced disease burden. • How to adapt treatment plans when interventions are unsuccessful. • The future of obesity care in gastroenterology. To collect CME credit for listening, visit agau.gastro.org.
This is episode 6 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely discuss: • The role of the gastroenterologists and hepatologists, gastroenterology and hepatology advanced practice providers (APP), and others in a care team for obesity management. • How to find information on coding and reimbursement for obesity management. • How treating obesity is beneficial for patients and practices. • Pearls from episodes 1-5 of the series. To collect CME credit for listening, visit agau.gastro.org.
In our final episode of our 5-part series Colorectal Cancer: Screening to Save Lives, we share updated information about coverage, cost-sharing, reimbursement and coding for colorectal cancer screening. In this episode: • David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center • Shivan Mehta, MD, assistant professor of medicine and health policy at Perelman School of Medicine and associate chief innovation officer at Penn Medicine Center for Innovation This season is supported by an independent medical education grant from Exact Sciences.
This is episode 4 of our 5-part series Colorectal Cancer: Screening to Save Lives. We talk about important considerations when caring for individuals at high risk for poor outcomes in colorectal cancer due to social determinants of health. In this episode: • David Lieberman, MD, professor of medicine in the division of Gastroenterology and Hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center This season is supported by an independent medical education grant from Exact Sciences.
This is episode 3 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about the importance of primary care providers in identifying and managing patients at high risk for colorectal cancer. In this episode: • David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center • Swati Patel, MD, associate professor and director of the Gastrointestinal Cancer Risk and Prevention Center at the University of Colorado School of Medicine Anschutz Medical Campus. This season is supported by an independent medical education grant from Exact Sciences.
This is episode 2 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about strategies for promoting initiation of colorectal cancer screening at age 45 and addressing early-onset colorectal cancer. In this episode: • David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center • Samir Gupta, MD, associate professor of clinical medicine at the University of California San Diego and the San Diego Veterans Affairs Healthcare System This season is supported by an independent medical education grant from Exact Sciences.
This is episode 1 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode covers what clinicians need to know regarding the updated colorectal cancer screenings guidance from the U.S. Preventive Services Task Force. In this episode: • David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center This season is supported by an independent medical education grant from Exact Sciences.
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion. In episode 1 of 4, we’ll discuss: • How do you explain biosimilars to a patient with moderate-to-severe Crohn’s disease when you start them on a biologic? • What are some of the common questions that patients ask and how do you address them? • Do you set goals of therapy with your patients and what are they? This series is supported by independent medical education grants from Amgen and Pfizer. To collect CME credit for listening, visit agau.gastro.org.
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion. In episode 2 of 4, we’ll discuss: • How do you prepare your team and the patient for a switch to a biosimilar? • Are there any situations where switching is not appropriate? • What do you think about multiple switches? • How do you minimize the potential for a nocebo effect? This series is supported by independent medical education grants from Amgen and Pfizer. To collect CME credit for listening, visit agau.gastro.org.